Efficacy News and Research

RSS

Population-level cohort study evaluates efficacy and safety of all COVID-19 vaccines used in Denmark

In a new study, researchers investigated the long-term efficacy, safety, and durability of all severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines used in Denmark.

13 Oct 2022

UH professor develops an imaging system to improve the view of cornea and fetal brain

Under the direction of Kirill Larin, high resolution optical coherence tomography (OCT) is having an extended moment.

12 Oct 2022

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC).

12 Oct 2022

Molecular signature could be mechanistically related to bleeding risk after heart surgery

Postoperative bleeding is one of the most common complications after cardiac surgeries, especially in open heart ones. In this kind of surgery, surgeons need to resort to cardiopulmonary bypass, an extracorporeal circuit composed of tubes and machines that replicate the function of the heart and lungs.

12 Oct 2022

The ability of antiviral formulation ViruSAL to inhibit SARS-CoV-2 infectivity

Researchers from Ireland used human bronchial epithelium models to evaluate the ability of a novel proprietary formulation called ViruSAL to inhibit SARS-CoV-2 infections.

12 Oct 2022

What is the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant?

A new review commented on a previous study regarding the real-world effectiveness of oral antivirals against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.

12 Oct 2022

The efficacy of UR GUV devices against aerosolized SARS-CoV-2

Researchers assessed the real-time inactivation of SARS-CoV-2 using ultraviolet-C.

12 Oct 2022

Observational study explores the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant

A new study reported the real-world efficacy of oral antiviral therapies nirmatrelvir plus ritonavir, and molnupiravir on the SARS-CoV-2 Omicron (B.1.1.529) variant, based on an observational study among coronavirus disease 2019 (COVID-19) patients in Hong Kong.

12 Oct 2022

The prevalence of COVID-19 vaccine hesitancy among the sub-Saharan adolescent population

Researchers examined the prevalence of COVID-19 vaccine hesitancy in the sub-Saharan adolescent population.

12 Oct 2022

Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients

A recent study determines the relationship between molnupiravir and nirmatrelvir-ritonavir and all-cause mortality.

12 Oct 2022

Clinical trial to test the safety, efficacy of bacteriophages for treating P. aeruginosa infections in CF patients

Cystic fibrosis (CF) is an inherited disorder that causes severe damage to the lungs and other organs in the body.

11 Oct 2022

Protoporphyrin IX delayed fluorescence imaging as a modality for hypoxia-based oncologic surgical guidance

In the surgical treatment of cancer, distinguishing between tumors and healthy tissues is critical. Fluorescent markers can help to do this, by enhancing the contrast of tumors during surgery.

11 Oct 2022

Are men or women impacted more by adverse reactions to prescription drug treatments?

Recently, researchers presented an overview of sex-based differences in adverse drug reactions (ADRs) based on epidemiology, technique, and underlying mechanism data.

11 Oct 2022

BNT162b2 COVID-19 booster vaccine induces robust humoral responses independent of the interval between the first two doses

A recent Cell Reports study evaluated humoral responses induced after the second and third doses of the mRNA vaccine.

11 Oct 2022

RNA-dependent RNA polymerase inhibitors in COVID-19 therapy

A new paper reviews current knowledge of RdRp inhibitors that could be developed further to provide broadly effective antivirals against SARS-CoV-2 in particular and CoVs in general.

10 Oct 2022

Factors associated with COVID‐19 vaccination hesitancy among French healthcare workers

A recent study describes the results from interviews of healthcare workers to determine factors associated with their vaccine hesitancy.

10 Oct 2022

Two popular drugs to treat type 2 diabetes performed best in large clinical trial

In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers from the University of Minnesota Medical School aided in the discovery that insulin glargine and liraglutide performed best.

7 Oct 2022

Study evaluates efficacy of a candidate SARS-CoV-2 subunit vaccine to protect endangered black-footed-ferrets

In a new study, researchers assessed the safety, efficacy, and immunogenicity of a candidate SARS-CoV-2 subunit vaccine in black-footed ferrets (BFF), and investigated the susceptibility of these endangered North American mammals to the virus.

7 Oct 2022

Vaccine-induced neutralizing and non-neutralizing antibody activity against SARS-CoV-2

A new study demonstrated that vaccine-induced antibody functions against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diminish with age.

7 Oct 2022

Study suggests an immunological benefit of combining previous natural infection with vaccination against COVID-19 using a combination of different vaccine platforms

Researchers explored SARS-CoV-2-targeted immune responses among COVAC1 participants who received a novel saRNA vaccine followed by the mRNA BNT162b2 vaccine BNT162b2 vaccine, with or without prior COVID-19 history.

7 Oct 2022

Efficacy News and Research

Population-level cohort study evaluates efficacy and safety of all COVID-19 vaccines used in Denmark

UH professor develops an imaging system to improve the view of cornea and fetal brain

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

Molecular signature could be mechanistically related to bleeding risk after heart surgery

The ability of antiviral formulation ViruSAL to inhibit SARS-CoV-2 infectivity

What is the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant?

The efficacy of UR GUV devices against aerosolized SARS-CoV-2

Observational study explores the real-world efficacy of oral antivirals against the SARS-CoV-2 Omicron variant

The prevalence of COVID-19 vaccine hesitancy among the sub-Saharan adolescent population

Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients

Clinical trial to test the safety, efficacy of bacteriophages for treating P. aeruginosa infections in CF patients

Protoporphyrin IX delayed fluorescence imaging as a modality for hypoxia-based oncologic surgical guidance

Are men or women impacted more by adverse reactions to prescription drug treatments?

BNT162b2 COVID-19 booster vaccine induces robust humoral responses independent of the interval between the first two doses

RNA-dependent RNA polymerase inhibitors in COVID-19 therapy

Factors associated with COVID‐19 vaccination hesitancy among French healthcare workers

Two popular drugs to treat type 2 diabetes performed best in large clinical trial

Study evaluates efficacy of a candidate SARS-CoV-2 subunit vaccine to protect endangered black-footed-ferrets

Vaccine-induced neutralizing and non-neutralizing antibody activity against SARS-CoV-2

Study suggests an immunological benefit of combining previous natural infection with vaccination against COVID-19 using a combination of different vaccine platforms

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News